Bevacizumab
Title: Bevacizumab for the treatment of colorectal cancer. Pre-Clinical study completed. Materials for Phase III studies 200gms generated at 500 L scale
Innovator: Vitane Biologics Private Limited(EPR Centre for Cancer Research and Bioinformatics)
Bevacizumab for the treatment of colorectal cancer. Pre-Clinical study completed. Materials for Phase III studies 200gms generated at 500 L scale